Author Archives: Alice Melão, MSc

Novoclem’s Candidate Therapy Shows Promise Against 9 Pathogens Associated with Cystic Fibrosis Infection

Novoclem Therapeutics’ lead drug candidate, a nitric oxide-releasing biopolymer, can eliminate nine of the most prevalent microorganisms responsible for severe lung infections in cystic fibrosis (CF) patients, the Morrisville, N.C., company reported. “Our mission is to arm patients with therapies that treat resistant bacteria and enable them to breathe…